The use of regenerative tools in gynecology is redefining how reproductive disorders are treated at the cellular level. Regenerative medicine in reproductive health introduces techniques aimed at restoring damaged tissues, especially in the uterus, ovaries, and fallopian tubes. Researchers are exploring biomaterials, platelet-rich plasma, and tissue-engineered constructs to repair endometrial lining and enhance ovarian responsiveness. These therapies offer new hope for women suffering from premature ovarian insufficiency, endometrial atrophy, or recurrent implantation failure. By shifting the therapeutic focus from symptom control to biological restoration, regenerative medicine may significantly expand fertility potential and improve patient outcomes. The personalization of regenerative approaches is a growing area of interest, particularly as researchers begin tailoring therapies to molecular profiles. Regenerative medicine in reproductive health combines cutting-edge biotechnology with reproductive science to offer a future where healing, rather than managing, becomes the clinical goal.